Asimov builds tools to program living cells. By integrating mammalian synthetic biology, computer-aided design, and machine learning, our multi-disciplinary team is advancing the design and manufacture of biologics and gene therapies.
Location: United States, Massachusetts, Boston
Employees: 11-50
Founded date: 2017
Investors 3
| Date | Name | Website |
| 11.06.2024 | Koch Disru... | kochdisrup... |
| - | DCVC | dcvc.com/ |
| 06.02.2021 | a16z | a16z.com/ |
Mentions in press and media 9
| Date | Title | Description |
| 20.05.2025 | Future of Biomanufacturing: AI-Driven Cell Line Development and Bioprocess Design, Upcoming Webinar Hosted by Xtalks | www.asimov.com In this free webinar, learn how biomanufacturing is evolving with the use of AI in cell line development and bioprocess design. Attendees will gain insight into the CHO Edge system, which is an integrated platform for genetic... |
| 18.09.2024 | Asimov launches AAV Edge, a suite of AI models, host cells, and genetic tools for end-to-end gene therapy development | High performance two-plasmid production system achieves E12 vg/mL unconcentrated titers AI-driven design tools to improve expression precision, efficacy, and manufacturability Boston, Massachusetts, 18 Sep 2024: Asimov, the synthetic biolog... |
| 29.04.2024 | Asimov achieves 10x improvement in lentiviral production, launches new stable cell line development service | Stable lentiviral (LV) cell line development service achieves unconcentrated titers >1E9 TU/mL for therapeutic transgenes. Fully stable cell lines have all viral genes and transgene stably integrated, enabling biomanufacturing scalabilit... |
| 29.01.2024 | Asimov launches LV Edge Packaging System to optimize lentivirus production | Asimov, the synthetic biology company advancing the design and manufacture of therapeutics, today announced the launch of their LV Edge Packaging System, which improves the cost efficiency and reduces the supply chain risk of lentiviral pro... |
| 27.03.2023 | Meet The Three Berkeley Dropouts Empowering Biotechs With Low-Code Cloud-Based Biocomputing | LatchBio founders: Alfredo Andere, Kenny Workman, and Kyle Giffin.LatchBio |
| 05.01.2023 | Drug Manufacturing Has One Huge Flaw. This Synthetic Biology Startup Just Raised $200 Million To Fix It. | The four Asimov co-founders, from left to right: Doug Densmore, Alec Nielsen, Raja Srinivas and ... [+] Chris Voigt.Asimov. |
| 07.11.2022 | Class of 2023 | From day one, Contrary’s mission has been to identify the brightest, scrappiest, and most talented builders in the world, and support them for life. Alongside many other initiatives, we do this with our community - and for the past 6 years,... |
| 10.01.2022 | New Year, New Fund, New Opportunities in Bio + Health | 2021 saw higher than ever funding of startups, continued maturation of the tech-enabled bio and healthcare landscape, and new platforms and business models that propelled growing levels of adoption and scale amongst both upstarts and tradit... |
| - | Asimov | “Asimov builds tools to program living cells. We're integrating mammalian synthetic biology with computer-aided design to advance therapeutic applications.” |